Home
Dice Therapeutics

Dice Therapeutics Market Share Analysis for April 2026

DICE brings together industry veterans with a passion for immunology and small molecule discovery. We envision a world where convenient oral medicines with biologic-like efficacy are available to patients with chronic diseases.

Health > Biotechnology and Pharmaceuticals

Domaindicetherapeutics.com

Year Founded2013

Employees51 - 200

Annual Revenue$1M - $2M

Dice Therapeutics

Dice Therapeutics (including company regionals)

dicetherapeutics.com

See more website traffic and engagement information

Dice Therapeutics Revenue up to April 2026 is 1M - 2M

revenue generated by Dice Therapeutics top domains

Dice Therapeutics top domains revenue over 3 years

Revenue for Dice Therapeutics top domains

dicetherapeutics.com1M - 2M

See more with Sales Intelligence

Total visits to Dice Therapeutics's top domains

Understand Dice Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Dice Therapeutics's top domains

Analyze Dice Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Dice Therapeutics's top domains

See how Dice Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Dice Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Dice Therapeutics

These are the website technologies, by industry, used by Dice Therapeutics top domains

Mobile (2)

Meta Viewport

Widget (2)

Google Maps

Advertising (1)

DoubleClick

Content Management System (1)

WordPress

More Technologies

5

See all

News & Signals from Dice Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLilly acquired DICE Therapeutics, Inc. for $2.4B on Jun 27th '23.E li Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

NewsAdvance Innovation Group acquires DICE Therapeutics, Inc..Reference : Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology.

NewsDICE Therapeutics, Inc. goes public.Lilly will buy Dice, a young biotechnology company that went public in 2021, for $48 per share in cash, the companies announced Tuesday.